Analystreport

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its price target lowered by analysts at Jefferies Financial Group Inc. from $70.00 to $53.00. They now have a "buy" rating on the s...

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com